Release date: 14 November 2007
Promoter – Financial Intermediary
Viveris ManagementLocation
Description
The proposed operation consists in an equity participation under EC MEDA II risk capital resources in two compartments of AlterMed: AlterMed Maghreb investing primarily in Morocco; and AlterMed Alternative Private Equity Fund (APEF) investing primarily in Tunisia.
Objectives
The two compartments in which the Bank intends to invest display innovative features. AlterMed Maghreb will target primarily leveraged buy-outs (LBOs), thereby supporting a niche not fully covered by other funds in Morocco. AlterMed APEF will support companies to be listed in the Tunisian alternative market, an initiative expected to be implemented by the end of 2007 and strongly supported by the Tunisian government as an opportunity to substantially increase the capitalisation of the stock market, still in its infancy stage.
Sector(s)
Proposed EIB finance (Approximate amount)
Up to EUR 11 million or 25% of the total commitments in any of the targeted compartments, whichever is lower.
Total cost (Approximate amount)
The target size of AlterMed Maghreb is expected to be EUR 25 million, and EUR 30 million for AlterMed APEF.
Environmental aspects
Not applicable
Procurement
Not applicable
Status
Signed - 13/12/2007
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).